MedPath

Excella GmbH & Co. KG

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

PHILIPPINES:8
SFDA:7

Drug Approvals

Uptravi

Approval Date
Jul 14, 2025
PHILIPPINES

Uptravi

Approval Date
Jul 14, 2025
PHILIPPINES

Uptravi

Approval Date
Jul 14, 2025
PHILIPPINES

Opsumit

Approval Date
Jul 14, 2025
PHILIPPINES

Uptravi

Approval Date
Jul 14, 2025
PHILIPPINES

Uptravi

Approval Date
Jul 14, 2025
PHILIPPINES

Uptravi

Approval Date
Jul 14, 2025
PHILIPPINES

Uptravi

Approval Date
Jul 14, 2025
PHILIPPINES

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.